What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-03-29 compared with 2022-06-13 · 29 added, 50 removed, 1 unchanged (99% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

of December 31, 2020, the Company’s common stock trades at low volumes on the OTCQB Tier of the OTC Markets under the symbol “BMTM.”

The approximate number of holders of record of the Company’s common stock at December 31, 2021 was 682.

The last sale price of

our common stock as reported on the OTCQB on June 30, 2021 was $0.45 per share.

The last sale price of our common stock as reported on

the OTC Pink Market on September 30, 2021 was $0.23 per share.

at the close of business on June 30, 2021 the Company’s stock ceased trading on the OTCQB and its shares began trading on the OTC

Pink Market on July 1, 2021.

The common stock will continue to trade with the symbol BMTM.

Effective September 30, 2021, the Company’s

stock ceased trading on the OTC Pink Market and began trading on the OTC EXPERT market.

Company has not declared nor paid any cash dividend on its common stock, and it currently intends to retain future earnings, if any,

to finance the expansion of its business, and the Company does not expect to pay any cash dividends in the foreseeable future.

whether to pay cash dividends on its common stock will be made by its board of directors, in their discretion, and will depend on the

Company’s financial condition, results of operations, capital requirements and other factors that its board of directors considers

sales of unregistered securities

2021, employees exercised 100,000 stock options for $13,900.

2021, employees exercised 25,000 warrants for $10,000.

2021, we issued 379,266 common shares to a vendor for services rendered valued at $1,762.

2021, we issued 7,919,017 shares of our common stock to an accredited investor upon the automatic conversation of 7,919,017 shares of

our 10% Series A convertible preferred stock together with accrued but unpaid dividends on those shares.

In accordance with the designations,

rights and preferences of the 10% Series A convertible preferred stock, those shares automatically converted into shares of our common

stock on a one for one basis on the fifth anniversary of the date of issuance of such shares.

The issuance of the shares of our common

stock upon the conversion were exempt from registration under Securities Act in reliance on an exemption provide by Section 3(a)(9) of

such act, and the issuance of the shares of our common stock as dividends on such shares were exempt from registration in reliance on

an exemption provided by Section 4(a)(2) of the Securities Act.

September 22, 2021, the Company entered into a share issuance settlement with Spartan Capital Securities, LLC (“Spartan”).

Under the terms of the agreement, the Company agreed to issue a total of 10,398,700 of its common stock to seventy-five accredited investors

who participated in the Company’s Private Placement Offering, which began in November 2019 and was completed in August 2020.

issuance was determined to be a deemed dividend.

2020, the Company sold an aggregate of 10,398,700 units of its securities to 167 accredited investors in a private placement exempt from

registration under the Securities Act in reliance on exemptions provided by Section 4(a)(2) and Rule 506(b) of Regulation D resulting

in gross proceeds to the Company of $5,199,350.

Each unit, which was sold at a purchase price of $0.50, consisted of one share of common

stock and one five-year warrant to purchase one share of common stock at an exercise price of $0.75 per share.

Spartan Capital Securities,

LLC (“Spartan Capital”) served as placement agent for the Company in this offering.

As compensation for its services, Spartan

Capital held back $779,903 for commissions, providing cash to the Company of $4,419,447.

From this amount, Spartan Capital deducted $165,000

to pay the accrued finder’s fee for the Oceanside acquisition, and $275,000 in other consulting fees, and $401,750 in success and

escrow fees resulting in net cash received by the Company of $3,577,697.

The Company issued Spartan Capital Placement Agents Warrants

to purchase an aggregate of 1,039,870 shares of our common stock, including the cash commission and Placement Agent Warrants issued pursuant

to the closings included in the Company’s consolidated statement of changes in stockholders’ equity for the year ended December

2020, a former employee exercised 50,000 stock options for $6,950.

A current employee exercised 80,000 stock options for $11,112.

of equity securities by the issuer and affiliated purchasers

As of August 19, 2022, the Company's Common Stock is currently quoted for trading on the OTCQB Market under the symbol "BMTM." Prior to August 19, 2022, the Company’s Common Stock was quoted for trading on the OTC Expert Market tier of the OTC Markets under the symbol “BMTM” from September 30, 2021 through August 18, 2022, quoted for trading on the OTC Pink Market under the symbol "BMTM" from July 1, 2021 to September 30, 2021, and quoted for trading on the OTCQB Market under the symbol “BMTM” from December 27, 2013 to June 30, 2021.

There was little to no trading of our common stock between January 1, 2022 to July 4, 2022, except for April 22, 2022, as the Company was in the process of restating its results for the year ended December 31, 2020, which resulted in the untimely filing of its results for the year ended December 31, 2021 and the subsequent interim quarter ended March 31, 2022.

The Company’s Common Stock trades at very low volumes.

The approximate number of holders of record of the Company’s Common Stock as of March 22, 2023, was 404.

The closing price of our Common Stock as reported on the OTCQB Market on December 30, 2022, was $0.16 per share.

The following table sets forth the high and low bid prices per share of our Common Stock as reported by the OTC Markets for the periods indicated.

The following quotations reflect inter-dealer prices, without retail mark-up, markdown or commission, and may not necessarily represent actual transactions.

December 31, 2022

1st Quarter (1)

2nd Quarter (2)

$ 0.001 $ 0.001

3rd Quarter $ 0.40 $ 0.40

4th Quarter $ 0.16 $ 0.16

December 31, 2021

1st Quarter $ 2.00 $ 2.00

2nd Quarter $ 0.45 $ 0.45

3rd Quarter $ 0.23 $ 0.23

4th Quarter (1)

(1) No trading as Company was in restatement period.

(2) Limited trading as Company was in restatement period.

Dividend Policy

The Company has paid or accrued dividends on shares of preferred stock pursuant to the terms of such preferred stock.

The Company has never declared nor paid any cash dividends on its Common Stock, and we do not expect to pay any cash dividends in the foreseeable future.

We currently intend to retain all available funds and any future earnings to fund the development and growth of our business.

The decision whether to pay cash dividends on our Common Stock will be made within the sole discretion of the Board, and will depend on the Company’s financial condition, results of operations, capital requirements and other factors that the Board considers significant.

There can be no assurance that any dividends on our Common Stock will ever be paid.

In addition, any future loan arrangements we enter into may contain, terms prohibiting or limiting the amount of dividends that may be declared or paid on our Common Stock.

Recent Sales of Unregistered Securities

Repurchases of Equity Securities

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity